PMID: 6104443Jul 1, 1980Paper

Overview: public health issues in tardive dyskinesia

The American Journal of Psychiatry
G Gardos, J O Cole

Abstract

Public health concern over tardive dyskinesia has been rising, but the magnitude of the problem has been undetermined. The incidence of tardive dyskinesia is unknown, and prevalence rates yield conflicting and possibly misleading estimates. The natural course of tardive dyskinesia is highly variable: in some patients (probably many fewer than previously believed) it is irreversible. No currently available therapeutic agent satisfies the criteria of safety, marked effectiveness, and prolonged efficacy in the treatment of tardive dyskinesia. Primary prevention involves reducing antipsychotic drug exposure, secondary prevention involves early diagnosis and prompt intervention, and tertiary prevention involves clinical measures to reduce disability and to treat severe cases vigorously. Educational methods that disseminate knowledge and influence prescribing habits need to be identified and used more widely.

Citations

Nov 30, 2014·Neurologic Clinics·Shyamal H MehtaKapil D Sethi
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·L K OyewumiR Gelfand
Jan 1, 1989·Progress in Neuro-psychopharmacology & Biological Psychiatry·S Wolfarth, K Ossowska
Jan 1, 1982·Community Mental Health Journal·M A MorellD V Perkins
Jan 1, 1983·Psychopharmacology·J G CsernanskyL E Hollister
Jun 1, 1981·Psychosomatics·N Pomara, S Gershon
Jan 11, 2005·Journal of the American Pharmacists Association : JAPhA·Douglas ShafferAnn Corken Mackey
Mar 1, 1982·Journal of the American Academy of Child Psychiatry·R L Zimmermann, G T Heistad
Jan 1, 1987·Journal of Chronic Diseases·H MorgensternS Holmberg
Feb 1, 1983·Journal of the American Geriatrics Society·M A Jenike
Mar 1, 1987·Journal of the American Geriatrics Society·C A PeabodyL E Hollister
Jan 1, 1987·Biological Psychiatry·C A PeabodyM D Warner
Jun 1, 1987·American Journal of Public Health·H MorgensternP Nourjah
Mar 11, 2005·Expert Opinion on Therapeutic Targets·James L RoerigKristine J Steffen
Jan 1, 1982·Acta Psychiatrica Scandinavica·R FreedmanP Denver
Aug 1, 1983·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·L K Oyewumi
Jun 24, 2021·Psychological Medicine·Andrew Scull

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
Robert Chaplin, A Kent
Annual Review of Medicine
D Tarsy, R J Baldessarini
The Journal of Clinical Psychiatry
Stanley N CaroffCATIE Investigators
The Annals of Pharmacotherapy
Jonathan G Leung, Ericka L Breden
The Australian and New Zealand Journal of Psychiatry
Robert Chaplin, Clive Timehin
© 2021 Meta ULC. All rights reserved